Ganciclovir Injection, Solution
Product Images NDC 51817-171

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ganciclovir (NDC 51817-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmascience Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box Label 1

Ganciclovir Injection is a sterile, nonpyrogenic, preservative-free cytotoxic agent used for intravenous infusion only. It is available in a single-dose vial containing 500mg/10mL of Ganciclovir and should be handled with great care due to its potent cytotoxic properties and suspected carcinogenic effect. The product is manufactured by Pharmascience Inc. in Candiac, Canada. For dosage recommendations and important prescribing information, refer to the accompanying insert.*

FDA Label Image

Box Label 25

FDA Label Image

Chemical Structure Of Ganciclovir Sodium And Ganciclovir (Ganciclovir Image 1 Chemical Structure)

FDA Label Image

Figure 1 Trial Icm 1653: Time To Progression Of Cmv Retinitis (Ganciclovir Image 2 Icm 1653)

This is a graph titled "ICM 1653: Time to Progression of CMV Retinitis". It shows the time from the start of maintenance therapy (in days) on the x-axis and the proportion without progression on the y-axis. The values range from 0-150 days and the highest proportion without progression is at day 60 with a value of 0.75.*

FDA Label Image

Figure 2 Trial Icm 1774: Time To Progression Of Cmv Retinitis (Ganciclovir Image 3 Icm 1774)

The text describes a graph or chart titled "ICM 1774: Time to Progression of CMV Retinitis". It shows the proportion of individuals with CMV retinitis who did not experience progression over time (measured in days) while receiving oral maintenance therapy. The graph starts at day zero and goes up to day 120.*

FDA Label Image

Figure 3 Trial Avi 034: Time To Progression Of Retinitis (Ganciclovir Image 4 Avi 034)

This is a graph labeled "AVI 034: Time to Progression of CMV Retinitis" which shows the proportion of patients without progression of CMV retinitis over time from the start of maintenance therapy, measured in days. The x-axis ranges from 0 to 150 days and the y-axis ranges from 0.25 to 0.75. There is no additional information available.*

FDA Label Image

Vial Label

Ganciclovir Injection is a sterile solution for intravenous infusion only. Each 10mL single-dose vial contains 500mg of ganciclovir. The container closure is not made with natural rubber latex and is sterile, nonpyrogenic and preservative-free. However, caution is advised as it is a cytotoxic agent and suspected carcinogen. Dosage information can be found in the package insert. The product should be handled with great care and any unused portion should be discarded. It is manufactured by Pharmascience Inc in Canada. Store at 25°C (17°F); excursions permitted to 15°-30°C (59°-46°F).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.